Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Kim MH et al. – The incidence of suspected adverse events and adverse event monitoring during AF rhythm–control and/or rate–control therapy is high. Costs associated with adverse events and adverse event monitoring are likely to add considerably to the overall burden of AF management.


   

Related Articles

Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data
Cancer Chemotherapy and Pharmacology, 10/05/09    Relevance Score: 68%

Drug-Induced Steatohepatitis Leading to Cirrhosis: Long-Term Toxicity of Amiodarone Use
Seminars in Liver Disease, 10/16/09    Relevance Score: 67%

Interindividual variability of drug transporters: Impact on opioid treatment in chronic renal failure
European Journal of Pain, 11/12/09    Relevance Score: 66%

Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Trends in Pharmacological Sciences, 10/29/09    Relevance Score: 66%

Monotherapy versus combination therapy for the treatment of chronic hepatitis B
Expert Opinion on Investigational Drugs, 10/26/09    Relevance Score: 66%

Today in Adverse Drug Reactions...keeping you current

Weight Gain and Insulin Resistance in Children Treated With Valproate: The Influence of Time
Journal of Child Neurology, 03/19/10

Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/19/10

A review of the effect of anticonvulsant medications on bone mineral density and fracture risk
The American Journal of Geriatric Pharmacotherapy, 03/19/10

Today in Pharmacoeconomics...keeping you current

Quadrivalent human papillomavirus (HPV) vaccine: a review of safety, efficacy, and pharmacoeconomics
Journal of Clinical Pharmacy and Therapeutics, 03/19/10

Cost Effectiveness of Etoricoxib versus Celecoxib and Non-Selective NSAIDS in the Treatment of Ankylosing Spondylitis
PharmacoEconomics, 03/16/10

Rifampicin reduces the plasma concentrations and the renin-inhibiting effect of aliskiren
European Journal of Clinical Pharmacology, 03/16/10


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address